EPOCAP 15144 PART A

Hazardous Ingredients

CAS Number GROUND LIMESTONE (CONTAINS LESS THAN 1% TRADE SECRET CRYSTALLINE SILICA) EPOXY RESIN 25068-38-6 BUTYL GLYCIDYL ETHER (BGE) 2426-08-6 *** ALL Ingredients in this product are listed in the T.S.C.A. Inventory SECTION III - HAZARDS IDENTIFICATION EYE CONTACT: PRODUCT MAY BE SEVERELY IRRITATING TO THE EYES. SKIN CONTACT: PRODUCT IS IRRITATING TO THE SKIN. PROLONGED OR REPEATED CONTACT CAN RESULT IN DEFATTING AND DRYING OF THE SKIN WHICH MAY RESULT IN SKIN IRRITATION AND DERMATITIS. PRODUCT MAY CAUSE SKIN SENSITIZATION. SKIN SENSITIZATION MAY BE EVIDENCED AS RASHES, ESPECIALLY HIVES. INHALATION: PRODUCT MAY CAUSE IRRITATION TO THE NOSE, THROAT AND RESPIRATORY TRACT. MAY PRODUCE CNS (CENTRAL NERVOUS SYSTEM) DEPRESSION. EARLY TO MODERATE CNS DEPRESSION MAY BE EVIDENCED BY HEADACHE, NAUSEA, GIDDINESS, AND DIZZINESS; IN EXTREME CASES, UNCONSCIOUSNESS AND DEATH MAY OCCUR. INGESTION: PRODUCT IS SLIGHTLY TOXIC AND MAY BE HARMFUL IF SWALLOWED. AGGRAVATED MEDICAL CONDITIONS: PREEXISTING SKIN AND EYE DISORDERS MAY BE AGGRAVATED BY EXPOSURE TO THIS PRODUCT. PREEXISTING SKIN OR LUNG ALLERGIES MAY INCREASE THE CHANCE OF DEVELOPING INCREASED ALLERGY SYMPTOMS FROM EXPOSURE TO THIS PRODUCT. HEALTH HAZARD INFORMATION: OTHER HEALTH INFORMATION (EPOXY RESIN): CHRONIC STUDIES: RECENT 2 YEAR BIOASSAYS IN MICE EXPOSED BY THE DERMAL ROUTE TO EPOXY RESIN, THE DIGLYCIDYL ETHER OF BISPHENOL A (DGEBPA), OR TO RESINS PREDOMINANTLY OF DGEBPA HAVE YIELDED VERY LIMITED EVIDENCE OF WEAK CARCINOGENICITY. DGEBPA IS A COMPONENT OF THE RESIN IN THIS PRODUCT. THE AU- THORS OF THIS WORK CONCLUDED THAT THE RENAL TUMOR EVIDENCE WITH THIS RESIN "WAS OF NO BIOLOGICAL SIGNIFICANCE" AND THAT THE RESIN "IS NOT A SYSTEMIC CARCINOGEN WHEN APPLIED TO THE DORSAL SKIN OF CF 1 MICE." IARC CONCLUDED THAT DGEBPA WAS NOT CLASSIFIABLE AS A CARCINOGEN (IARC GROUP 3) BASED ON THE FOL- LOWING: HUMAN AND ANIMAL EVIDENCE BOTH INADEQUATE. MUTAGENICITY: BOTH THE RESIN AND DGEBPA, HAVE PROVED TO BE INACTIVE WHEN TESTED BY IN VIVO MUTAGENICITY ASSAYS. THEY HAVE BOTH SHOWN ACTIVITY BY THE IN VITRO MICROBIAL MUTAGEN- ICITY SCREENING AND HAVE BOTH PRODUCED CHROMOSOMAL ABERRA- TIONS IN CULTURED RAT LIVER CELLS. THE SIGNIFICANCE OF THIS INFORMATION TO MAN IS UNKNOWN. HAZARDOUS FILLER WARNING FOR SILICA (LEVELS LESS THAN 1%): THIS FORMULA CONTAINS HAZARDOUS FILLERS WHICH ARE NOT HAZARDOUS IN A WET OR ENCAPSULATED STATE. HOWEVER, IF A FORMULA CONTAINING A HAZARDOUS FILLER IS REDUCED TO A RESPIRABLE FRACTION BY GRINDING OR PUTTING INTO AN AIRBORNE POWDER, THE POWDER IS CONSIDERED A HAZARDOUS MATERIAL. IARC CLASSIFICATION FOR SILICA POWDER IS GROUP 1 (CARCINOGENIC TO HUMANS).